Themis Medicare Limited — Board Meeting, 13-06-2025: Outcome of Board Meeting

Themis Medicare has announced a board meeting and resolved to withdraw the proposed merger with Gujarat Themis Biosyn Limited. Gujarat Themis Biosyn will now focus on expanding its fermentation-based pharmaceutical intermediates and API business through organic growth and collaborations. Meanwhile, Themis Medicare will prioritize its domestic formulations segment, aiming for sustainable growth without pursuing the merger. Both companies are sharpening their focus on core areas to drive future progress.